-
Another Benefit of Esbriet for Patients with Pulmonary Fibrosis.
Are you a seasonal allergy sufferer on top of living with pulmonary fibrosis (PF)?
Do you take Esbriet for the management of your lung disease?
If so, recent results from a study out of the University of California San Francisco (UCSF) might be appeal to you. A research poster presented by Brett Ley, MD (pulmonologist) recently outlined these findings at the 2018 American Thoracic Society International Conference. Below is an excerpt from a column published on our main Pulmonary Fibrosis News site regarding this study:
Seasonal flares of disease activity that can lead to idiopathic pulmonary fibrosis (IPF) patients being hospitalized, especially in the winter months, appear to be effectively countered by treatment with Esbriet (pirfenidone) compared to placebo, a new retrospective analysis of data from Phase 3 clinical trials shows.
More information can be found by reading the full column on Pulmonary Fibrosis News.
If you currently take Esbriet and find yourself a sufferer of seasonal allergies, have you noticed an improvement in your allergy-related symptoms since taking this medication?
Log in to reply.